Nature Study Sparks Fierce Debate: Do Pfizer and Moderna Vaccines Offer Cancer Immunity Upgrades?
Researchers are analyzing a Nature article suggesting COVID-19 mRNA vaccines (Pfizer/Moderna) might enhance immune response against cancer. The discussion centers on survival data involving immunotherapy treatments.
The core argument involves patient survival rates. 'loldog191' initially pointed to data suggesting vaccine recipients had a higher chance of three-year survival near immunotherapy. However, 'loldog191' then contested this, noting the benefit seemed specific to the mRNA vaccine, not just standard flu shots. Meanwhile, an anonymous commenter floated a highly theoretical take, describing survival from infection as an evolutionary 'upgrade' where the body incorporates viral DNA.
The discussion shows a split focus: some accept the research direction, as noted by 'Angelevo,' while others aggressively debate the study's statistical validity. The divide rests on whether observed survival increases are truly vaccine-linked or simply artifacts of unmeasured confounding variables, like baseline sickness levels.
Key Points
Vaccinated patients showed statistically higher three-year survival rates post-immunotherapy.
Initial claims by 'loldog191' were raised, but subsequent analysis by 'loldog191' questioned the replicability of this boost against non-mRNA vaccines.
The immune effect of mRNA vaccines on cancer fighting is the primary focus.
Multiple users, including 'Rhaxapopouetl', grounded the talk in the specific findings reported in Nature.
Survival benefits might be skewed by pre-existing patient health status.
The skepticism from 'loldog191' suggested that inherent differences in the unvaccinated group could skew the survival statistics.
Infection survival suggests a form of biological 'upgrade' or mutation.
An uncredited commenter posited that surviving infection means the host integrates foreign genetic material, framing it as an evolutionary step.
Source Discussions (3)
This report was synthesized from the following Lemmy discussions, ranked by community score.